The Cytokines Market is undergoing a profound structural transformation as it reaches a valuation of USD 106.14 billion in 2026. While the sector has traditionally been dominated by North American infrastructure, the current year marks a pivotal shift in global distribution and technological deployment. The industry is moving beyond simple protein replacement toward high-complexity...